Related Experiment Video
Updated: Aug 4, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Opportunities and challenges in targeting orphan nuclear receptors
Laura Isigkeit1, Daniel Merk1,2
1Goethe University Frankfurt, Institute of Pharmaceutical Chemistry, 60438 Frankfurt, Germany. daniel.merk@cup.lmu.de.
Abstract:
Nuclear receptor modulation enables pharmacological control of gene expression thus rendering the 48 human nuclear receptors as attractive targets for drug discovery. Several nuclear receptor ligands like glucocorticoids are approved and highly important drugs illustrating the therapeutic potential of nuclear receptor modulation. However, a significant portion of the nuclear receptor family is still poorly explored for new therapeutic opportunities which is due to a lack of potent, selective and well-characterized ligands. Preliminary evidence supports great therapeutic potential of several orphan nuclear receptors in various pathologies underlining the need for high-quality chemical tools to enable target validation. Here, we evaluate the characteristics of available nuclear receptor modulators and the gaps in coverage of the nuclear receptor family with chemical tools. We review successful approaches to nuclear receptor modulator development and highlight the opportunities and challenges in closing the gaps of missing tools for understudied nuclear receptors to open new therapeutic avenues.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Signal Transduction: Overview
Typically, signal transduction involves three...
Regulation of Nuclear Protein Sorting
Introduction to Nuclear Reprogramming
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

